Objectives: To test whether ciprofloxacin, moxifloxacin and clarithromycin affect the expression of the T helper (Th) cell cytokines, interferon-g and interleukin-4. Quinolone and macrolide antibiotics are routinely used for the treatment of critically ill patients with sepsis. These antibiotics modulate some aspects of immune cell function. Alteration in the profile of Th cell cytokine expression will affect the T helper cell ratio and subsequent immune responses.
Introduction
Fluorinated-4-quinolones, including ciprofloxacin and moxifloxacin, are nalidixic acid analogue antibiotics, which exert their bactericidal effect by inhibiting DNA gyrase activity. Ciprofloxacin has been shown previously to have immunomodulatory effects (recently reviewed by Dalhoff and Shalit 1 ), and although moxifloxacin is a relatively new drug, it too has been shown to be immunomodulatory in both animals and humans. 2, 3 Clarithromycin is a semi-synthetic acid-stable member of the broad-spectrum macrolide family and has been shown to modulate release of several cytokines. 4, 5 T helper lymphocytes are important for both cell-mediated and humoral immunity. 6 The particular type of immune response is determined by the differentiation of precursor naive T helper (Th0) cells into Th1 or Th2 cells, a process which is dependent upon local cytokine concentrations, antigen load and mode of antigen presentation. Each cell subset secretes a particular array of cytokines which further augment the differentiation into that subset. 7, 8 Th1 cells produce predominantly interferon-g (IFN-g) and favour cell-mediated immune responses, while Th2 cells secrete predominantly interleukin-4 (IL-4) and favour humoral immunity.
The effects of ciprofloxacin, moxifloxacin and clarithromycin on intracellular expression of T helper cell cytokines and the ratio . of Th1/Th2 subsets have not been investigated. Since the balance of cytokines produced in response to infection will have a marked effect on T helper subset predominance and hence the nature of subsequent immune responses, we investigated whether these antibiotics had modulatory effects on the Th1 cytokine IFN-g, and the Th2 cytokine IL-4.
Materials and methods
Following local research ethics committee approval and informed consent, blood samples were taken into lithium heparin from 20 healthy volunteers (10 men/10 women, aged 21-48 years). Peripheral blood mononuclear cells were isolated by single density gradient centrifugation as previously described 9 and adjusted to a concentration of 1 · 10 6 cells/mL in RPMI 1640 medium with Glutamax-I (Gibco-Invitrogen, Paisley, UK) supplemented with 10% heat-inactivated fetal calf serum (Helena Biosciences, Sunderland, UK) and 10% sodium pyruvate (Gibco-Invitrogen). Cells were incubated in 5 mL flow cytometry tubes for 4 h in a humidified atmosphere of 95% air/5% CO 2 at 37 C, with 20 ng/mL (10 mL) phorbol myristate acetate (PMA; Sigma-Aldrich, Gillingham, UK), 1 mmol/mL (10 mL) ionomycin (Sigma-Aldrich) and 0.67 mL/mL (5 mL) monensin (BD Biosciences, Cowley, UK).
Ionomycin and PMA are pharmacological T cell activating agents which mimic signals generated by the T cell receptor (TCR) complex and have the advantage of stimulating T cells of any antigen specificity. 10, 11 Monensin is a protein transport inhibitor which retains synthesized proteins within the cell, and therefore increases the sensitivity of intracellular cytokine staining. 12 Some cells were also exposed to 5, 20, 50 or 100 mg/L ciprofloxacin; 2, 10, 20 or 50 mg/L moxifloxacin, or 5, 20, 50 or 125 mg/L clarithromycin (all 100 mL). Ciprofloxacin and moxifloxacin were a gift from Bayer Plc, Newbury, UK and clarithromycin was a gift from Abbott Laboratories Ltd, Queensborough, UK. During the incubation, tubes were mixed every 30 min to maintain cells in suspension. Appropriate positive and negative controls for flow cytometer calibration and compensation were also included. Cell controls included stimulated and unstimulated cells with every combination of antibody and unstimulated cells with antibiotic. In some experiments, antibiotics were added up to 4 h after cell stimulation.
Isolated mononuclear cells were washed in staining buffer (phosphate-buffered saline containing 1% fetal calf serum and 0.1% sodium azide) and stained for 30 min with allophycocyanin (APC)conjugated anti-CD4 (all antibodies from Caltag-Med Systems, Towcester, UK) and fluorescein isothiocyanate (FITC)-conjugated anti-CD3 plus IgG control antibodies, before washing in staining buffer and re-suspending in 4% paraformaldehyde. For intracellular staining, cells were permeabilized with 0.1% saponin, washed, and then incubated with phycoerythrin (PE)-conjugated anti-IFN-g or anti-IL-4 at 4 C for 30 min in the dark before being resuspended in 1% paraformaldehyde.
Cells were analysed using a FACScan flow cytometer (Becton Dickinson) with two lasers (488 and 580 nm) with filter settings for APC at 640 nm, FITC at 515 nm and PE at 585 nm. Following calibration, 10 000 cells were analysed from each tube and analysis gates were set on CD3-and CD4-positive lymphocytes according to both forward and side scatter profiles. IFN-g + or IL-4 + cell populations were isolated from the gated T helper lymphocyte populations (CD3 + and CD4 + ) and the percentage of positive cells was determined. Data were not normally distributed and are therefore expressed as median and range and were statistically analysed using Friedman 1-way ANOVA by ranks (using c 2 approximation and correction for ties) to test for difference between related samples, with post-hoc testing using Wilcoxon signed ranks test. Independent data sets were compared using the Mann-Whitney U-test.
Results
The number of lymphocytes expressing either intracellular IFN-g or IL-4 increased significantly when cells were stimulated with ionomycin and PMA compared to unstimulated cells (P < 0.0001, Figure 1a -c). Analysis of variance indicated that moxifloxacin and ciprofloxacin decreased the number of cells expressing both IFN-g and IL-4 in stimulated cells (all P < 0.0001, Figure 1a and b) in a concentration-dependent manner. Post-hoc analysis showed that the number of cells expressing IFN-g was lower in those treated with 20, 50 or 100 mg/L ciprofloxacin (P < 0.05, Figure 1a ) and the number expressing IL-4 was lower in cells treated with 5, 20, 50 or 100 mg/L ciprofloxacin (P < 0.05, Figure 1a ). The number of cells expressing either IFN-g or IL-4 was significantly lower than in the absence of antibiotic in the cells treated with 2-50 mg/L moxifloxacin (all P < 0.05, Figure 1b ).
Only the percentage of cells expressing IL-4 however, was affected by clarithromycin exposure (P = 0.003, Figure 1c ). The number of cells expressing IL-4 was significantly lower than without antibiotic in samples treated with 20, 50 or 125 mg/L clarithromycin (P < 0.05, Figure 1c ).
Despite the changes in the numbers of cells expressing IFN-g and IL-4, there was no significant change in the ratio of the number of IFN-g-positive to IL-4-positive cells (Th1/Th2 ratio) in cells exposed to moxifloxacin or ciprofloxacin. In clarithromycin-treated cells, however, the Th1/Th2 ratio was significantly higher at the highest concentration of clarithromycin (P = 0.017, Table 1 ).
None of the antibiotics had any effect on IL-4 or IFN-g in the absence of stimulation. When antibiotics were added up to 4 h after ionomycin and PMA stimulation, there was no change in the percentage of cells expressing either IFN-g or IL-4. Cell viability determined using Trypan Blue exclusion was consistently above 95% after incubation with antibiotics with and without stimulation.
Discussion
We have shown in this study that both ciprofloxacin and moxifloxacin caused a concentration-related decrease in the numbers of stimulated human Th cells expressing IFN-g and IL-4, without affecting the ratio of the number of IFN-g-positive (Th1) to IL-4positive (Th2) cells. Clarithromycin treatment, however, caused a decrease only in the number of cells expressing the Th2 cytokine, IL-4, resulting in a significant increase in the Th1/Th2 ratio.
Although cytokines are essential for the resolution of infection and injury, prolonged production may result in host tissue and organ damage. Several antibiotics, including quinolones and macrolides, have been shown to have modulatory effects on cytokine release. [1] [2] [3] [4] [5] Clearly, it is important to define the immunomodulatory activity of antibiotics and other drugs used to treat patients since these properties may have clinical significance, particularly in patients who are immunodeficient or patients on the intensive care unit.
Although bacterial infection is considered to develop Th1polarized responses, the ability of pathogens to stimulate preferentially either Th1 or Th2 responses depends on several factors including genetic background of host, type of infecting organism, stage of infection and microbial load. [6] [7] [8] When antibacterial agents inhibit cytokine generation with variable effects on either Th1-or Th2-cytokines, they may alter or reinforce the Th response induced by microbial infection. It is believed that serious injury results in predominance of the Th2 phenotype as opposed to the Th1 phenotype, rather than generalized Th suppression. 13, 14 It is also generally considered that Th1 predominance is associated with cell-mediated responses which are most beneficial to recovery.
A shift to Th2-dominated phenotypes increases the risk for infection, for example after burn injury. 14 Major burns induce a significant shift of cytokine response in the Th2 direction. 14 We have also reported that the Th1/Th2 ratio is significantly lower in patients with sepsis than both non-septic controls and healthy subjects, due to both a decrease in Th1 cells and an increase in Th2 cells. 10 Polarization of CD4-positive Th cells toward either a Th1 or Th2 response can significantly influence host immunity to pathogens. IFN-g and IL-4 are the signature cytokines of Th1 and Th2 cells, respectively. At an early stage of development, Th1 and Th2 populations are heterogeneous with a reversible cytokine profile, suggesting that a number of molecular changes are needed for committed profiles of cytokine gene expression. The control of T helper cell differentiation is a function of a number of factors; the most important of which is cytokine environment. There appear to be two 'master switches' which control Th cytokine commitment. 7, 8, 15 IL-4 is the principal cytokine driving naive T cells (Th0) to Th2 differentiation. IL-4 is synthesized by differentiating Th2 cells and by fully differentiated Th2 cells. 15 The human IL-4 promoter consists of multiple DNA binding motifs, which bind several classes of transcription factor. The GATA-binding protein 3 (GATA-3) is a Th2-specific regulatory factor necessary to direct T helper cells to Th2 differentiation. 16, 17 We have shown that all three antibiotics decreased IL-4 expression by Th2 cells. The mechanisms of this are not clear. There are no reports of the effect of antibiotics on GATA-3. However, like the macrolides and quinolones, the opiate morphine has wide ranging immunomodulatory effects including effects on Th cytokines, and IFN-g and IL-4 promoter activities. Recently, morphine was also shown to increase GATA-3 expression in murine splenocytes and may suggest a similar mechanism for antibiotic effects. 18 Acute expression of IL-4 by Th2 cells is also regulated by nuclear factor kB (NF-kB), nuclear factor of activated T cells (NFAT), activator protein-1 (AP-1) and interferon regulatory factor-1 (IRF1). 15 Effects on activation of AP-1 and NFAT by ciprofloxacin have been described, 19 although we previously found no effect of ciprofloxacin on either AP-1 or NF-kB in human endothelial cells. 20 Such discrepancies are probably related to cell type, cell stimulant and co-stimulatory conditions. A recent study reported that clarithromycin repressed promoter activity in an AP-1 binding site, but not in an NF-kB-like site. 21 Clarithromycin can inhibit oxidant production by neutrophils 22 and both AP-1 and NF-kB are redoxsensitive transcription factors, which may provide another possible mechanism for the effect of clarithromycin on transcriptional activation. Indeed, other agents with antioxidant properties can inhibit IL-4 via this mechanism. 23 The effects of clarithromycin in our study are in agreement with another recent study, which found suppressive effects of macrolides including clarithromycin, on IL-4 but not IFN-g. 24 The key cytokine for promoting Th1 differentiation is IFN-g. 7,8 A number of transcription factors play an important role in regulation of IFN-g including NFAT, NF-kB and IRF-1. However, Th1 lineage commitment and IFN-g expression seem to be controlled by the Th1-restricted transcription factor protein T-bet, which is able to initiate Th1 differentiation while repressing Th2 differentiation. 25 The effect of antibiotics on T-bet has not been studied, although a recent study showed that morphine treatment resulted in decreased T-bet mRNA levels. 18 However, it is not clear whether this is a consequence of an increase in GATA-3 expression or a direct effect of morphine acting on the signalling pathways that regulated T-bet expression.
The choice of concentration in the studies of antibiotic effects is crucial in terms of clinical relevance. Both moxifloxacin and ciprofloxacin are concentrated in cells, so it is important to study a range of concentrations. 26, 27 Although serum levels of clarithromycin are lower than the level at which we found an effect on Th ratios, it is important to note that concentration of this drug in peripheral leucocytes can reach around 50 mg/L and up to 400 mg/L in alveolar macrophages. 28 In summary, we have shown that both quinolone (ciprofloxacin and moxifloxacin) and macrolide (clarithromycin) antibiotics have marked effects on Th cell cytokines, with implications for immune responses and recovery after severe infection. The mechanisms of such effects are not known, but since the antibiotics only exert their effects after cell stimulation, recently identified so-called 'master switches' for Th cell cytokine control may represent targets for future investigation of antibiotic action.
